| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
2024 FINANCIAL FORECAST
The Company provides the following updated financial forecast for full year 2024 and initial forecast for Q2 2024, in both instances reflecting management's expectations based on the most current information available.
Full Year 2024
| METRIC ($ in millions) | Updated Range (as of 05/01/2024) | Action | Previous Range (as of 03/06/2024) |
| Total revenues | $1,000 - $1,100 | REVISED | $900 - $1,100 |
| Net loss | $(148) - $(98) | REVISED | $(183) - $(133) |
| Adjusted net loss (2) | $(65) - $(15) | REVISED | $(130) - $(80) |
| Adjusted EBITDA (2) | $125 - $175 | REVISED | $50 - $100 |
| Total segment adjusted gross margin % (2) | 44% - 47% | REVISED | 40% - 45% |
| Segment Level Revenue (4) | |||
| Commercial Products | $460 - $500 | UNCHANGED | $460 - $500 |
| MCM Products | $440 - $490 | REVISED | $340 - $490 |
| Services | $70 - $80 | UNCHANGED | $70 - $80 |
| Key Assumptions ($ and shares in millions) | Updated Range (as of 05/01/2024) |
| Interest expense | ~$82 |
| R&D | ~6% of Revenue |
| Weighted avg. fully diluted share count | ~52 |
| Capex | ~$32 |
| Depreciation & amortization | ~$111 |
Q2 2024
| METRIC ($ in millions) | Q2 2024 Forecast |
| Total revenues | $160 - $210 |
Posted In: EBS
